Prevalence of Pre-Treatment Sarcopenia in Patients Newly Diagnosed with Lymphoma
Sarcopenia prevalence was 3%, but 22% had low muscle mass, suggesting muscle strength alone may not be an optimal screening tool for lymphoma patients.
Authors
- Charlotte N Grønset (ORCID: https://orcid.org/0000-0002-7125-3676)
- Mary Jarden (ORCID: https://orcid.org/0000-0003-3040-8384)
- Anders Tolver (ORCID: https://orcid.org/0000-0003-1109-9889)
- Martin Hutchings (ORCID: https://orcid.org/0000-0003-3873-1741)
- Charlotte Suetta (ORCID: https://orcid.org/0000-0001-8063-6508)
- Jan Christensen (ORCID: https://orcid.org/0000-0003-1114-7465)
Institutions
- University of Copenhagen (DK)
- Frederiksberg Hospital (DK)
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
- Danish Cancer Society (DK)
Publication Details
- Journal
- Acta Haematologica
- Published
- 2025-04-05
- DOI
- https://doi.org/10.1159/000545358
- Primary Topic
- Nutrition and Health in Aging
- Type
- article
- Field-Weighted Citation Impact
- 0.00